Singapore Stock Market News

iX Biopharma Ltd - IPO Fast Sheet

StockFanatic
Publish date: Thu, 16 Jul 2015, 11:44 AM
StockFanatic
0 10,453
Welcome to Stockfanatic Singapore stock market and regional market news. This is a platform to share Singapore stock market and regional news to investors / man in the street. Investors can also look forward to analyst reports and brokers recommendations. Stockfanatic's Singapore stock market and regional news blog, home of investors one stop news station.

BACKGROUND
iX Biopharma focuses on the development and commercialisation of innovative therapies for pain management and male erectile dysfunction. The group currently has three drugs under development - WafermineTM, WafernylTM and PheoniXTM, and operates an integrated business model encompassing drug development, manufacturing and supply.

BUSINESS STRATEGY AND FUTURE PLANS
Develops and commercialises its products to gain market share in Australia and other parts of the world.

Expands portfolio of products by developing a pipeline of products incorporating proprietary drug delivery technology to address unmet or under-served therapeutic needs.

Collaborates with third parties to expand product reach into other geographical regions.
Read more »
Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment